These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 20306453

  • 1. Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care.
    McDowell SE, Coleman JJ, Evans SJ, Gill PS, Ferner RE.
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):482-9. PubMed ID: 20306453
    [Abstract] [Full Text] [Related]

  • 2. Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.
    Coleman JJ, McDowell SE, Evans SJ, Gill PS, Ferner RE.
    Br J Clin Pharmacol; 2010 Jul; 70(1):109-17. PubMed ID: 20642553
    [Abstract] [Full Text] [Related]

  • 3. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG.
    Circulation; 2009 Oct 20; 120(16):1598-605. PubMed ID: 19805653
    [Abstract] [Full Text] [Related]

  • 4. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 20; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 5. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
    Chapman RH, Petrilla AA, Berman L, Benner JS, Tang SS.
    Am J Cardiovasc Drugs; 2009 Jan 20; 9(5):299-308. PubMed ID: 19791839
    [Abstract] [Full Text] [Related]

  • 6. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J.
    Ann Pharmacother; 2005 Sep 20; 39(9):1401-8. PubMed ID: 16076920
    [Abstract] [Full Text] [Related]

  • 7. Persistence with treatment for hypertension in actual practice.
    Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD.
    CMAJ; 1999 Jan 12; 160(1):31-7. PubMed ID: 9934341
    [Abstract] [Full Text] [Related]

  • 8. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP.
    J Hum Hypertens; 2005 Aug 12; 19(8):607-13. PubMed ID: 15920457
    [Abstract] [Full Text] [Related]

  • 9. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM.
    Am J Ophthalmol; 2005 Oct 12; 140(4):598-606. PubMed ID: 16226511
    [Abstract] [Full Text] [Related]

  • 10. Blood pressure control in patients initiating antihypertensive therapy.
    Weycker D, Edelsberg J, Vincze G, Levy DG, Kartashov A, Oster G.
    Ann Pharmacother; 2008 Feb 12; 42(2):169-76. PubMed ID: 18182472
    [Abstract] [Full Text] [Related]

  • 11. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J.
    Can J Cardiol; 1997 Oct 12; 13(10):914-20. PubMed ID: 9374947
    [Abstract] [Full Text] [Related]

  • 12. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug 12; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care.
    Halme L, Vesalainen R, Kaaja M, Kantola I, HOme MEasuRement of blood pressure study group.
    Am J Hypertens; 2005 Nov 12; 18(11):1415-20. PubMed ID: 16280273
    [Abstract] [Full Text] [Related]

  • 15. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep 12; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 16. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA, McClure DL, Chan KA, Simon SR, Feldstein AC, Lafata JE, Andrade SE, Gunter MJ, Nelson WW, Roblin D, Platt R.
    Ann Pharmacother; 2007 Feb 12; 41(2):193-200. PubMed ID: 17284506
    [Abstract] [Full Text] [Related]

  • 17. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Grant RW, Singer DE, Meigs JB.
    Clin Ther; 2005 Jun 12; 27(6):773-81. PubMed ID: 16117984
    [Abstract] [Full Text] [Related]

  • 18. Improved blood pressure control by monitoring compliance with antihypertensive therapy.
    Waeber B, Vetter W, Darioli R, Keller U, Brunner HR.
    Int J Clin Pract; 1999 Jun 12; 53(1):37-8. PubMed ID: 10344064
    [Abstract] [Full Text] [Related]

  • 19. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 12; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.